Mark S. Levine insider trades

Open-market stock purchases and sales by Mark S. Levine, Chief Legal Officer at Immunovant, Inc, from SEC Form 4 filings since Sep 2, 2014.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • IMVT Immunovant, Inc: 23 sales, last Nov 20, 2024
  • FLXN Flexion Therapeutics Inc: 3 sales, last Nov 19, 2021
  • NERV Minerva Neurosciences, Inc: 2 sales, last Jun 1, 2017

Get free alerts when Mark S. Levine files a new trade →